| Literature DB >> 12682214 |
Christophe Rousselle1, Philippe Clair, Maria Smirnova, Yuri Kolesnikov, Gavril W Pasternak, Stephanie Gac-Breton, Anthony R Rees, Jean-Michel Scherrmann, Jamal Temsamani.
Abstract
The blood-brain barrier restricts the passage of substances into the brain. Neuropeptides, such as enkephalins, cannot be delivered into the brain when given systemically because of this barrier. Therefore, there is a need to develop efficient transport systems to deliver these drugs to the brain. Recently, we have demonstrated that conjugation of doxorubicin or penicillin to peptide vectors significantly enhances their brain uptake. In this study, we have conjugated the enkephalin analog dalargin with two different peptide vectors, SynB1 and SynB3, to improve its brain delivery and its pharmacological effect. We show by in situ brain perfusion that vectorization markedly enhances the brain uptake of dalargin. We also show using the hot-plate model that this enhancement in brain uptake results in a significant improvement in the observed antinociceptive effect of dalargin. These results support the usefulness of peptide-mediated strategies for improving the availability and efficacy of central nervous system drugs.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12682214 DOI: 10.1124/jpet.102.048520
Source DB: PubMed Journal: J Pharmacol Exp Ther ISSN: 0022-3565 Impact factor: 4.030